Status:
NOT_YET_RECRUITING
Innovative OSA Screening in Head and Neck Cancer Patients With the Apneal App
Lead Sponsor:
University Hospital, Caen
Collaborating Sponsors:
Mitral
Conditions:
Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS)
Head and Neck Cancers
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Obstructive sleep apnea syndrome is a common but often underdiagnosed condition, with significant impacts on quality of life, such as fatigue, attention disorders, and an increased risk of heart attac...
Eligibility Criteria
Inclusion
- Adult patients undergoing diagnostic workup for a lesion suspected to be a head and neck cancer, followed by confirmation of the malignant nature of the lesion. The following locations will be included: the nasopharynx, nasal cavities, sinuses, oral cavity, oropharynx, hypopharynx, larynx, and parotid gland.
- The collection of the informed consent signature is required.
- The patient must be affiliated with the social security system.
Exclusion
- Minor patients, or those under judicial protection, guardianship, or curators.
- Lack of confirmation of the malignant nature of the lesion.
- Diagnosis of metastatic cancer.
- Known history of obstructive sleep apnea syndrome (OSAS) or previously treated head and neck cancer.
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06896448
Start Date
April 1 2025
End Date
May 1 2026
Last Update
March 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Caen
Caen, France, France, 14000